These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 9506565
1. Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Villalba L, Hicks JE, Adams EM, Sherman JB, Gourley MF, Leff RL, Thornton BC, Burgess SH, Plotz PH, Miller FW. Arthritis Rheum; 1998 Mar; 41(3):392-9. PubMed ID: 9506565 [Abstract] [Full Text] [Related]
2. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial. Hamaguchi T, Shirao K, Yamamichi N, Hyodo I, Koizumi W, Seki S, Imamura T, Honma H, Ohtsu A, Boku N, Mukai T, Yamamoto S, Fukuda H, Yoshida S, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821 [Abstract] [Full Text] [Related]
3. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. Carmichael SJ, Beal J, Day RO, Tett SE. J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315 [Abstract] [Full Text] [Related]
5. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators. Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [Abstract] [Full Text] [Related]
8. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. Garrett AP, Garner EO, Goldstein DP, Berkowitz RS. J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874 [Abstract] [Full Text] [Related]
9. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE, Bochkova AG, Bunchuk NV. Ter Arkh; 2008 May; 80(5):25-30. PubMed ID: 18590110 [Abstract] [Full Text] [Related]
10. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. Buckley LM, Vacek PM, Cooper SM. J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565 [Abstract] [Full Text] [Related]
11. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice. Stone JH, Tun W, Hellman DB. J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980 [Abstract] [Full Text] [Related]
12. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial. Fleischmann RM, Cohen SB, Moreland LW, Schiff M, Mease PJ, Smith DB, Keenan G, Kremer JM, iRAMT Study Group. Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527 [Abstract] [Full Text] [Related]
16. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. Kremer J, Genovese M, Cannon GW, Caldwell J, Cush J, Furst DE, Luggen M, Keystone E, Bathon J, Kavanaugh A, Ruderman E, Coleman P, Curtis D, Kopp E, Kantor S, Weisman M, Waltuck J, Lindsley HB, Markenson J, Crawford B, Fernando I, Simpson K, Strand V. J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730 [Abstract] [Full Text] [Related]
17. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone. O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD. Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240 [Abstract] [Full Text] [Related]
18. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Lehman AJ, Esdaile JM, Klinkhoff AV, Grant E, Fitzgerald A, Canvin J, METGO Study Group. Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810 [Abstract] [Full Text] [Related]
19. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhovens R, Luyten FP, Corluy L, Houssiau FA, Verschueren P. Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189 [Abstract] [Full Text] [Related]
20. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, Hessey EW, Shaw TM, DANCER Study Group. Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]